OncoMatch

OncoMatch/Clinical Trials/NCT07150624

The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine

Is NCT07150624 recruiting? Yes, currently enrolling (Sep 2026). This Phase 4 trial studies Experimental Group for hepatocellular carcinoma (hcc).

Phase 4RecruitingAnhui Provincial HospitalNCT07150624Data as of Sep 2026Location: China

Treatment: Experimental GroupA multicenter, open-label, randomized, controlled study. It is proposed to evaluate the treatment plan of receiving 930mg polyene phosphatidylcholine injection one day before the operation, twice a day, and 930mg polyene phosphatidylcholine injection twice a day,combined with 100mg of magnesium isoglycyrrhizinate injection once a day,from the 1st to the 5th day after the operation. Compared with the monotherapy regimen of no liver protection treatment before the operation and receiving magnesium isoglycyrrhizinate injection 100mg once a day from the 1st to the 5th day after the operation.The efficacy and safety of treating postoperative liver function injury in patients undergoing laparoscopic hepatectomy for hepatocellular carcinoma were compared.

Check if I qualify

Extracted eligibility criteria

Treatments studied

Other

Experimental Group

Cancer type

Hepatocellular Carcinoma

Performance status

ASA 1–3

Demographics

Ages ≤ 70

Prior therapy

Cannot have received: portal vein embolization

Cannot have received: systemic glucocorticoids

Lab requirements

Liver function

child-pugh grade a or b, with a score of ≤ 7; preoperative alt < 2x uln; preoperative icg r15 < 10%; residual liver volume/standard liver volume > 40%

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Frequently asked questions

Is NCT07150624 currently recruiting?

Yes, this trial is currently recruiting patients.

Are there prior therapy exclusions?

Yes. Prior portal vein embolization, systemic glucocorticoids disqualifies patients from enrollment.

Is there an age limit?

Yes. Patients must be 70 years or younger.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify